SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-043756
Filing Date
2024-04-11
Accepted
2024-04-11 16:53:58
Documents
11
Period of Report
2024-04-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tlis-20240410.htm   iXBRL 8-K 40976
  Complete submission text file 0000950170-24-043756.txt   185068

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tlis-20240410.xsd EX-101.SCH 47560
15 EXTRACTED XBRL INSTANCE DOCUMENT tlis-20240410_htm.xml XML 4890
Mailing Address 1100 ISLAND DRIVE SUITE 101 REDWOOD CITY CA 94065
Business Address 1100 ISLAND DRIVE SUITE 101 REDWOOD CITY CA 94065 650-433-3000
Talis Biomedical Corp (Filer) CIK: 0001584751 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40047 | Film No.: 24839119
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)